Theralase Technologies Inc. V.TLT

Alternate Symbol(s): V.TLT.WT | TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Durable Response

<< Previous

Bullboard Posts

Next >>

Comment by Eoganachton Jun 10, 2022 8:47am

179 Views

Post# 34746492

RE:RE:Durable Response

Hi Infinity - I was just looking at the sum of the CR and pending in order to estimate potential CR which is a simplification. It's possible some of the PR patients could become CR but that would just improve the CR rate. For the purposes of the table potential CR = Total patients treated - PR + NR

Infinity wrote: Eoga, I like the way that you presented. However, You have accounted for all the 41 patients at different date intervels. Whatever happend to the No Response group of patients. It looks as though the NO Response group has been added to the Pending response ??

<< Previous

Bullboard Posts

Next >>

New Found Gold begins surface trenching at Queensway